Neoadjuvant chemoradiation may be associated with improved pathologic response in pancreatic cancer

Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life data

(2019) Sophia Chikhladze et al.   World Journal of Surgical Oncology

Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer?

(2018) Jin He et al.   ANNALS OF SURGERY

Metabolic Dependencies in Pancreatic Cancer

(2018) Ali Vaziri-Gohar et al.   Frontiers in Oncology

Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer

(2016) Matthew H. G. Katz et al.   JAMA Surgery

Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer

(2015) Eisar Al-Sukhni et al.   ANNALS OF SURGICAL ONCOLOGY

Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer

(2014) Christina L. Roland et al.   ANNALS OF SURGICAL ONCOLOGY

Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis

(2011) Qing Zhao et al.   Annals of Diagnostic Pathology

Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma

(2011) Deyali Chatterjee et al.   CANCER

Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced Survival

(2009) James M. Donahue et al.   ANNALS OF THORACIC SURGERY